FOXP3 and hepatocellular carcinoma: In this study, we further demonstrated that the pre-S2 mutant-positive patients exhibited a higher density of CD4+CD25+ cells and Foxp3-expressing cells concurrent with a similar CTLs but lower granzyme B-expressing cells in HCC tissues compared with the pre-S2 mutant-negative patients.